Medtronic ADAPT study results published in The Lancet Diabetes & Endocrinology show improved glycemic control and treatment satisfaction among those using MiniMed™ 780G system¹, compared to insulin injectionsPRNewsWire • 09/01/22
Medtronic announces partnership with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearable for continuous remote patient monitoring from in-hospital to homePRNewsWire • 08/31/22
Cloud DX to Present on Teladoc Partnership and More at Emerging Growth ConferenceAccesswire • 08/30/22
Medtronic Extravascular ICD meets global pivotal clinical trial's safety and effectiveness endpointsPRNewsWire • 08/28/22
Raymond James downgrades Medtronic to market perform on doubts around revenue growthMarket Watch • 08/24/22
Medtronic plc (MDT) CEO Geoff Martha on Q1 2023 Results - Earnings Call TranscriptSeeking Alpha • 08/23/22
Medtronic Narrowly Beats Earnings Forecasts, Though Declines ContinueInvestors Business Daily • 08/23/22
Earnings Preview: Medtronic (MDT) Q1 Earnings Expected to DeclineZacks Investment Research • 08/16/22